Serotonin synthesis inhibition as novel therapeutic option in Pulmonary Hypertension associated with Left Heart Disease (PH-LHD)
| Institution | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) |
|---|---|
| Project leader | Natalia Alenina |
| Site | Berlin |
| Project type | Translational Research Project |
| Funding | € 75.000,00 |
| Begin | 01.01.2026 |
| End | 30.06.2027 |
Förderkennzeichen
81X2100191
Projektnummer
2053